Presently, skeletal dosimetry models utilized in clinical medicine simulate electron path lengths through skeletal regions based upon distributions of linear chords measured across bone trabeculae and marrow cavities. In this work, a human thoracic vertebra has been imaged via nuclear magnetic resonance ͑NMR͒ spectroscopy yielding a three-dimensional voxelized representation of this skeletal site. The image was then coupled to the radiation transport code EGS4 allowing for 3D tracing of electron paths within its true 3D structure. The macroscopic boundaries of the trabecular regions, as well as the cortex of cortical bone surrounding the bone site, were explicitly considered in the voxelized transport model. For the case of a thoracic vertebra, energy escape to the cortical bone became significant at source energies exceeding ϳ2 MeV. Chord-length distributions were acquired from the same NMR image, and subsequently used as input for a chord-based dosimetry model. Differences were observed in the absorbed fractions given by the chord-based model and the voxel transport model, suggesting that some of the input chord distributions for the chord-based models may not be accurate. Finally, this work shows that skeletal mass estimates can be made from the same NMR image in which particle transport is performed. This feature allows one to determine a skeletal S-value using absorbed fraction and mass data taken from the same anatomical tissue sample. The techniques developed in this work may be applied to a variety of skeletal sites, thus allowing for the development of skeletal dosimetry models at all skeletal sites for both males and females and as a function of subject age.
I. INTRODUCTION

A. Skeletal dosimetry models based on chord-length distributions
The trabecular portion of the skeleton consists of a network of interlaced spicules of bone ͑trabeculae͒ that delineate cavities containing active and inactive bone marrow. The work performed by the research group of F.W. Spiers at the University of Leeds [1] [2] [3] [4] [5] [6] [7] established the framework for performing radiation particle dosimetry in these regions of the skeleton. To calculate dose in trabecular bone, one must describe in some fashion the 3D geometry through which beta particles travel while continually depositing their kinetic energy. Frequency distributions of linear path lengths ͑chord-length distributions͒ across both bone trabeculae and marrow cavities provide this required data.
There are essentially two options for utilizing Monte Carlo techniques in the calculation of absorbed fractions of energy using chord-length distributions. The first option is to transport each particle in such a way that the traversed distance across a given medium exactly equals the sampled chord length. While this method does not create a 3D geometric model realistic in appearance of true marrow cavities and bone trabeculae, energy loss patterns in the two media are modeled in an approximate fashion. The second option is to use the chord distribution data to create such a geometrical model. The Leeds group only intended their chord-length distributions to be used under the first option. The latter option is exceedingly difficult as demonstrated previously by Rajon et al. in their construction of a synthetic mathematical model of a human vertebra. 8 The Leeds data have since served as the basis for almost all subsequent trabecular bone dosimetry models published to date. 4, 5, 7, [9] [10] [11] [12] [13] [14] [15] It is important to consider the properties of this geometrical data and how they should be used in dosimetry calculations. The Spiers chord distributions are normalized frequency distributions of linear path lengths through either the bone or marrow regions. Their use in dosimetry studies thus limits the spatial transport of the beta particle to a fixed distance for a given sampled chord length. Of course, one of the main assumptions in this method is that beta particles travel in approximately straight path lengths through both tissue regions. It would be theoretically improper to use the chord distributions to setup a 3D geometrical description of a marrow cavity, where the electron could travel a straight-line distance different than the chord sampled from the chord-length distribution.
Naturally, the Spiers research group was the first to use their chord distribution data in beta-particle dosimetry. 4, 5, 7 These methods utilized Monte Carlo techniques to randomly and alternately sample from their measured bone and marrow chord distributions to determine the pattern of their energy deposition in either bone or marrow regions of the skeletal site. The Whitwell study 6 coupled the experimentally measured chord-length distributions with range-energy relationships to calculate conversion factors ͑dose per unit activ-ity concentration in bone͒ for seven radionuclides of interest in health physics ͑ 14 C, 18 F, 22 Na, 32 P, 45 Ca, 90 Sr, 90 Y͒. In their study, only volume-and surface-seeking radionuclides were considered, and only the marrow and endosteum were chosen as target regions.
Other uses of the Spiers chord distribution data include ͑1͒ the work of Snyder in the development of radionuclide S values for radiopharmaceutical dosimetry, 16, 17 ͑2͒ the work of the ICRP in its Report 30 18 and the adoption of that model into the MIRDOSE2 dosimetry code, 12 ͑3͒ the work of Eckerman and Stabin in the development of the skeletal models underlying the MIRDOSE3 dosimetry code, [10] [11] [12] and ͑4͒ the work at the University of Florida by Bouchet et al. in 3D transport using these chord distributions. [13] [14] [15] A schematic of the transport process utilized in the Bouchet et al. model is shown in Fig. 1 .
B. Potential limitations of chord-length-based dosimetry models
While the Bouchet et al. model is believed to be an improvement over the one-dimensional models that do not allow path length deviations in a given skeletal region, the model does rely on the assumption that the true path length does not deviate significantly from the straight-line displacement. It should be obvious that while these chord-lengthbased models for transport seem theoretically correct, they all rely on a few basic assumptions. The degree to which these assumptions affect the accuracy of dosimetry results has so far been indeterminate. The present work attempts to quantify the accuracy of these assumptions by providing an alternate voxel-based transport model for electron sources in trabecular bone.
The 3D model of Bouchet et al. contains several theoretical improvements over 1D models in that it allows for nonlinear path lengths for particle transport, as well as backscattered electrons, delta rays, and bremsstrahlung photons. While this treatment should allow for more realistic transport and energy deposition, it also presents the following theoretical limitation, especially for low-energy electrons. If a particle encounters a large angular scatter along its path ͑up to 90°is allowed in the model͒, the sampled chord length will no longer be accurate. In other words, if the particle exhibits a large angular deviation, it is likely that the effective straight-line pathlength subsequently seen by the particle in the true skeletal geometry would be different. This is the fundamental assumption of any chord-length-based dosimetry model: straight-line pathlengths can be used to simulate the electron transport paths through trabeculae and marrow regions. Dosimetry results following a full 3D transport in a voxelized geometry of the trabecular bone region would serve as a basis for testing this fundamental assumption.
Additionally, chord-length-based models assume that the bone and marrow cavity chord distributions are independent of one another. Chord-length-based models randomly and alternately sample from the marrow and bone distributions. In our companion paper, we show preliminary evidence that bone and marrow chord lengths are not statistically independent. 19, 20 Current chord-length-based models do not account for such an association.
Separate but similar to the chord-length association, is a possible angular association. A chord-length-based model generally assumes an isotropic microstructure through which the particle is transported. It has been shown that many skeletal sites exhibit anisotropy, especially in stress-bearing bones such as vertebra. [21] [22] [23] [24] Furthermore, the chord-length-based models have had to use rough approximations to account for the macroscopic dimensions of the cortical bone cortex that encompasses the trabecular regions of a skeletal site. Other models have neglected particle loss at the cortical bone boundaries. These latter models treat the skeletal site as an infinite ''sea'' of trabecular bone in which all initial electron energy is fully deposited only within the site's trabecular region. The work of Whitwell did make allowances for ''the finite sizes of the bones, which result in some energy escape from the structure'' when calculating skeletal averages for her dose factors. 6, 7 For large skeletal sites like the vertebra, the assumption of total electron energy deposition is sufficiently accurate, especially at moderate-to-low electron energies. However, this assumption may not hold true for high-energy electrons or in skeletal sites such as the cranium, clavicle, scapula, ribs, and sacrum, whose cortical bone cortex represents a substantially large fraction of the total volume of the bone site.
C. EGS4 electron transport code
The models used in this work require the accurate simulation of photon and electron transport in different media. The Electron Gamma Shower Version 4 ͑EGS4͒ along with its PRESTA algorithm was utilized in this research. [25] [26] [27] This code is commonly used for medical internal dosimetry and has been benchmarked extensively. The maximum percent energy loss per electron transport step ͑ESTEPE͒ was set to 0.02. Energy cutoffs were set to 1 keV. All results shown in this work were from 10 runs of 1000 particles ͑10 000 total histories͒. Coefficients of variation on the absorbed fractions were typically less than a few percent.
II. MATERIALS AND METHODS
A. Using NMR microscopy images as input to voxel transport
Building on a previously developed voxel array transport methodology, 19 ,28 a code was written in which a segmented 3D NMR image of the trabecular regions of a human thoracic vertebra is used as the basis for the transport geometry within EGS4. Each voxel within the segmented and filtered NMR image is 59ϫ59ϫ78 m 3 in size. The image used in this work was obtained previously on a 600-MHz ͑14.1 T͒ NMR spectrometer. Details of image acquisition and image processing can be found in a previous publication. 29 The cylindrically cored sample, provided to us from the UF Tissue Bank, was taken from within a block of four vertebral bodies harvested from the thoracic section of a 52-year-old male trauma victim.
For each voxel in the segmented image, one of two transport media is assigned: marrow or osseous tissue. The atomic composition of osseous tissue needed to simulate the voxels within skeletal trabeculae is taken from data given in ICRU Publication 46 for cortical bone. 30 It is assumed that the atomic composition of the trabeculae is similar to cortical bone. The atomic composition of the marrow voxels is taken as a weighted average of the compositions of red marrow and yellow marrow, both of which are given in ICRU Publication 46. The mass percentage of red marrow to total marrow ͑the cellularity factor͒ in the thoracic vertebra is taken as 70% as defined in Table II of Cristy for Reference Man. 31 Note that, in this approach, the active marrow is assumed to be uniformly distributed within the marrow cavities ͑identical composition within all marrow voxels͒.
B. The ROI-restricted transport model
In the studies conducted with EGS4, three transport models were constructed, each with increasingly realistic considerations of the true skeletal region geometry. The first and most simplistic model is an ROI-restricted transport model. Here, a region of interest within the segmented NMR image, one identical to that used to acquire marrow and trabecular chord-length distributions, is coupled to the EGS4 voxel array transport code. Transport of electrons and photons is performed within this region. When a particle exits the region, it is discarded. Results from this model are subsequently used to assess the need for particle reintroduction to the image ROI as a function of the particle's initial kinetic energy. The region of interest ͑ROI͒ selected was 140ϫ100ϫ140 voxels in size (8.26 mmϫ7.80 mmϫ8.26 mm) corresponding to a total volume of trabecular bone of 532 mm 3 .
C. Method for scoring energy deposition to the trabecular endosteum
Scoring energy deposition within the thin endosteal layer on the surfaces of trabeculae requires a special subroutine. When energy deposition takes place within a marrow voxel, a subroutine is called to determine if that event occurred in a marrow voxel bordering a bone trabecula. If the marrow voxel is not adjacent to the bone surface, the full energy deposition is scored to the marrow. If the event occurs within a marrow surface voxel, an endosteal dose scoring algorithm is called in which the floating-point location of the energy deposition event with respect to the endosteal surface is determined. After finding the location of the neighboring bone voxels, the perpendicular distance to those voxels is calculated. If the energy-loss event to bone surface distance is less than 10 m, the event is scored as occurring within the endosteum. Otherwise, the energy deposition is scored strictly to the marrow tissues. This technique is particularly appropriate when the electron step size in the transport is much less than the 10 m thickness of the endosteal layer.
D. The infinite trabecular region transport model
This model builds on the previous ROI-restricted transport model. The former code is modified so that if a particle leaves the region of interest it is reintroduced back into the image ROI. This model effectively creates an infinite geometry of trabecular bone. In this manner, the transport code generates absorbed fraction data equivalent to all previously developed models that use chord-length distributions as input and make no corrections for particle loss to cortical bone. In the only chord-length-based model to account for these losses, Whitwell did apply an ''equilibrium factor'' which utilized information on the macroscopic dimensions of a bone site. 6, 7 The algorithm reintroduces the particle randomly within the image ROI, with the condition that it is placed within the same medium ͑bone or marrow͒ and with the same relative direction as when the particle exits the ROI. The particle is introduced with the same direction to preserve any anisotropy preference that may exist within the sample image. The potential effect of anisotropy within the sample's microstructure will only be seen in this study, and will not affect the results of the other models. Note that technically the ROI is shifted while the particle remains stationary, so as to not alter the values of the various EGS4 transport parameters during the period of reintroduction.
E. The macrostructural transport model
This final transport model is based on modifications to the previous infinite trabecular region transport model. Here, the particles ͑both electrons and photons͒ are allowed to leave the trabecular region, enter the cortical bone cortex of the bone site, and potentially leave the bone site altogether. This task is accomplished by transporting the particles in a manner similar to that used in the infinite model. However, this time an additional macroscopic cortical bone boundary is monitored relative to the particle's floating-point location within the ROI of the NMR image.
The macroscopic dimensions of the thoracic vertebra specimen, as well as the thickness of the cortical bone cortex, were determined through the use of 2D NMR images acquired on a 200 MHz ͑4.7 T͒ spectrometer ͑see Figs. 4͑a͒-͑c͒ of Ref. 29͒. These images are of the same bone specimen from which cored samples were taken and imaged on the higher-resolution 600 MHz spectrometer. Figures 4͑a͒-͑c͒ of Ref. 29 display single slices of the vertebral block as viewed in the transverse, coronal, and sagittal planes, respectively. In this particular tissue specimen, the vertebral processes were removed during sample harvest. Consequently, the macrostructural model was subsequently developed specific to the trabecular regions of the vertebral body, which contain a large fraction of the total marrow space of the bone site.
It was determined that a semi-cylindrical geometry would best approximate the macroscopic boundaries of the thoracic vertebral body ͑see Fig. 2͒ . Note that the geometry is not a perfect semi-cylinder in that a specified distance is used to offset the plane across the z-axis. Measurements of cortical thickness were taken from the 2D NMR images. A cortex of cortical bone was placed on all sides of the trabecular region, and was assigned a thickness of 1.04 mm. No significant variation in the thickness of the cortical region with location was noted in the 200 MHz images and thus a single uniform cortical thickness was used to create a cortex around the trabecular region of the vertebral body. This value is consistent with observations by Whitwell that the cortical thickness of the adult vertebrae is ''very thin'' ͑Whitwell thesis, Table  4 .1͒. 6 In the macrostructural transport model, a particle is transported via reintroduction to the trabecular region ROI until it reaches the interior edge of the cortical bone boundary within the corresponding macroscopic bone model. At that point, the particle is no longer transported within the voxels of the image ROI, but is instead transported within a continuous region of cortical bone. If the particle reenters the trabecular region of the macroscopic model, it is simultaneously reintroduced within the voxels of the image ROI. If the particle exits on the exterior or periosteal surface of the cortical shell, it is discarded. At this stage of model development, no consideration is given to the periosteal tissues as a distinct target region.
F. Method of S-value calculation
For electron transport in trabecular bone, three sources and targets are considered: the trabecular bone volume ͑TBV͒, the trabecular marrow space ͑TMS͒, and the trabecular bone endosteum ͑TBE͒. 32 The Medical Internal Radiation Dose ͑MIRD͒ Committee has established a schema for internal dose estimation. 33 This method determines the absorbed dose to a target region as the product of the cumulated activity in the source region and a parameter, the S value, which gives the absorbed dose to the target per unit cumulated activity in the source region:
According to the MIRD schema, S values for specific radionuclides are calculated for a source region r S and a target region r T : 
where ⌬ i is the mean energy emitted per nuclear transition, i (r T ←r S ) is the absorbed fraction of energy in the target region for the ith radiation type originating in the source region, and m T is the mass of the target region. The nuclear decay data are taken from Eckerman et al. 34, 35 These files partition the composite beta-particle spectrum for each radionuclide into approximately 100 monoenergetic electron energy bins, each with its own fractional particle yield.
As discussed previously, absorbed fractions are calculated using the results from the EGS4 transport calculations. The energy emitted per transition is well known, leaving the target mass as the only remaining parameter needed to assess radionuclide S values and absorbed doses to skeletal marrow. At present all skeletal dosimetry models have derived skeletal tissue masses from sources completely separate from those used to calculate absorbed fractions. Reference Man marrow mass data giving both ͑1͒ the site-specific relative fractions of total marrow in skeletal and ͑2͒ the percent of total body mass attributed to total marrow ͑ϳ5% of 70 kg͒ come from a study performed by Mechanik in 1926 in Russia. 36 In this work, the skeletons from 13 cadavers ͑6 males and 7 females͒ were cleaned, weighed, removed of marrow by maceration, and then re-weighed with the difference in mass assigned to the mass of total marrow. As reported by Woodard, 37 the bodies of these individuals were somewhat but not excessively emaciated having suffered from a variety of wasting illnesses ͑tuberculosis, senile marasmus, malaria, etc.͒. As such, Woodard comments that data from these studies should be ''applied with caution to normal individuals.'' 37 Despite these precautions, this data has been adopted for use as Reference Man marrow masses within a wide variety of trabecular bone dosimetry models. [10] [11] [12] [13] 18 These models are all chord-length-based models and thus a separate and independent assignment of marrow masses is necessary to report radiation doses per unit uptake or nuclear decay within the skeleton.
To calculate masses of active, inactive, and total marrow, cellularity factors must additionally be assigned. The cellularity factor is the ratio of active marrow mass to total marrow mass within a given skeletal site. These factors were reported for Reference Man by Cristy 31 and were additionally tabulated in ICRP Publication 70. 38 The dry weights of the skeleton are also tabulated in ICRP 70 and were originally measured by Trotter and Hixon in 1974 based on 30 white males. 39 Endosteal mass measurements have been obtained from the surface-to-volume ratios and an assumed endosteal thickness of 10 m. 13, 40 Given this widely disparate data set of skeletal masses needed for a comprehensive skeletal dosimetry model, the inherent attributes of a skeletal dosimetry model based upon 3D NMR microscopy, or other 3D imaging modality, become apparent. Using 3D microimaging of trabecular bone, target region masses and absorbed fractions can be assembled from the same anatomic sample. All mass measurements can be based on the same region of interest of the NMR image within which radiation transport is performed. First, the total volume of the trabecular region is calculated based on the macroscopic boundaries of the sample. Next, the fraction of bone and marrow voxels in the region of interest is used to estimate the total volume of bone trabeculae within the thoracic vertebral body. Multiplying the total bone volume by the density of adult cortical bone ͑1.92 g cm
Ϫ3
͒ yields the total mass of the trabecular bone volume or TBV.
To determine the mass of the trabecular marrow space ͑TMS͒, trabecular active marrow ͑TAM͒, trabecular inactive marrow ͑TIM͒, and trabecular bone endosteum ͑TBE͒, other measurements from the NMR images are necessary. First, the volume of endosteum must be subtracted from the estimated marrow space volume. Scanning the ROI of the NMR image and counting the number of bone/marrow surfaces gives a rough estimate of total trabecular surface area within the ROI. This value will overestimate the true surface area due to the jagged representation of the bone marrow interface introduced through the voxelization process. The total volume of trabecular bone endosteum within the vertebral body is thus estimated as the product of ͑1͒ the total trabecular surface area within the image ROI, ͑2͒ the 10 m endosteal reference thickness, and ͑3͒ the volume ratio of trabecular bone within the entire macroscopic model to that within the image ROI. Next, one can multiply by the density of endosteum ͑1.03 g cm Ϫ3 ͒ thus giving the total trabecular bone endosteal mass within the bone site.
The total marrow volume is estimated through subtraction given the previous volume estimates of both the bone trabeculae and the endosteal tissues. The density of the marrow space is taken to be 1.03 g/cm 3 yielding a mass estimate for the total trabecular marrow space ͑TMS͒. Finally, cellularity factors from ICRP 70 are used to partition the TMS mass into that of trabecular active marrow ͑TAM͒ and trabecular inactive marrow ͑TIM͒. Table I summarizes the derivation of these masses for both the ROI of the NMR image as well as the entire thoracic vertebral body used in this study.
III. RESULTS AND DISCUSSION
A. ROI-restricted transport
The ROI-restricted transport model does not allow for reintroduction of particles. Once a particle reaches the exterior of the region of interest it is discarded. Consequently, the discarded energy increases with increasing electron source energy. This was evident in the results for all three source regions. Figures 3-6 show the energy dependence of the absorbed fraction for the ROI-restricted transport model given various combinations of source and target tissues as indicated in the figure captions. Results are also shown for the two remaining, and more realistic, transport models as discussed below.
B. Infinite trabecular region transport
In this second model of particle transport, the particle is reintroduced within the voxel array when it reaches the edge of the image's region of interest. Full energy deposition is thus required within the trabecular bone regions of the bone site ͑vertebral body͒. As a result, with increasing particle initial energy the absorbed fractions for each of the three target tissues should approach target-specific convergence values. Further, these convergence values at high electron energies become independent of the source location of the emissions ͑bone marrow, bone endosteum, or bone volume sources͒.
Convergence values for each of the target regions are derived in the Appendix. For example, the absorbed fraction to the trabecular marrow space for high-energy electrons emitted from source region, S, may be expressed in terms of masses within the trabecular bone site:
͑3͒
where m TM S , m TBE , and m TBV are the masses of the marrow space, bone endosteum, and bone volume ͑trabeculae͒, respectively, within the skeletal site, and (dT/ dx) c is the collisional mass stopping power for either osseous tissue ͑TBV͒
Similar expressions for the convergence values to the TBE and TBV as target regions are given in the Appendix. Using stopping power data from ICRU Report 46, 30 as well as target region masses given in Table I 
are between 7% and 9%. In a separate study by Rajon et al., 8, 41 it was shown that transport in voxelized samples could be accurately performed at resolutions as large as 200ϫ200 ϫ200 m 3 for electron energies about 300 keV.
C. Macrostructural transport
Finally, the macrostructural transport model uses the defined macroscopic boundaries of the cortical bone cortex to approximate the spatial extent of the trabecular bone region within the thoracic vertebral body. As shown in Figs. 3-6 , the absorbed fractions for the macrostructural model initially tend toward the same asymptotic value found for the infinite trabecular region model. At electron initial energies exceeding ϳ2.0 MeV, however, particle escape to the vertebral body cortex becomes significant for trabecular and marrow space sources. At these energies, one observes a downturn in the absorbed fraction to targets internal to the trabecular regions of the bone site, a feature not accounted for in the infinite trabecular region model. Figure 3 presents comparisons of the three models for the trabecular marrow space serving as both source and target. In the energy range from 10 to 100 keV, all the models produce similar results. For energies greater than 100 keV, the marrow self-absorbed fraction for the ROI-restricted model begins to fall away from the results given by the other models. Thus it can be deduced that the reintroduction of particles becomes significantly important at energies greater than 100 keV for this NMR microscopy sample. The volume of the image region of interest is large enough to accurately describe absorbed fractions below 100 keV. The infinite trabecular region and macrostructural models produce identical results for energies up to ϳ2.0 MeV. At this point, energy loss to the cortical bone cortex and the vertebral body exterior boundary becomes significant within the latter model. Figure 4 presents the same comparison for a monoenergetic electron source in the marrow space irradiating an endosteum target, (TBE←TM S). As discussed earlier, a method was developed for scoring energy deposition within the endosteal region. Similar energy trends are noted: particle reintroduction is important above 100 keV, and particle escape to the cortex of the vertebral body influences the absorbed fraction at source energies above 2 MeV. Figures 5  and 6 show the corresponding results and model comparisons for bone volume sources and for marrow space and bone endosteum targets, respectively.
D. Comparisons to chord-length-based models
The chord-length distributions derived in previous work 19, 20 were used as input to the trabecular bone transport model of Bouchet et al. 14 Figure 7 displays a comparison of absorbed fractions for the marrow space as both source and target, (TM S←TM S). The Bouchet et al. model was run with chord-length distributions derived, not from the Spiers data, but from the same image used to define the voxel transport geometry within the macrostructural model. Differences between the Bouchet et al. model and the macrostructural model at high energies is most likely due to different pathlengths traveled by the particles under the two very different transport methodologies.
As a verification of their results at high electron source energies, Bouchet et al. calculated an asymptotic convergence value for absorbed fractions to a marrow space target. This value, given by Eq. ͑A9͒ in the Appendix, is based on mean chord lengths across the three transport regions ͑TMS, TBE, and TBV͒ taken from the same chord-length distributions used as input to their model. Using Eq. ͑A9͒ with the chord-length distributions taken for the present NMR image, one verifies that the results for the Bouchet et al. model are internally consistent with this modeling approach ͑the absorbed fraction should approach 0.66 at high energies͒. For the full voxel-based transport within the macrostructural model, the predicting expression for the convergence value is more fundamentally expressed in terms of mass fraction ͓Eqs. ͑3͒ and ͑4͔͒. Here one predicts a convergence of the absorbed fraction for full 3͑D͒ voxel transport to a value of 0.78. Figure 7 shows that this value is approached with in- creasing electron source energy until ϳ2 MeV where energy loss to the vertebral body cortex becomes significant. The overall conclusion is that both models are internally consistent, and thus the 10% underestimate of absorbed fraction given by the chord-length-based model is most likely a reflection of the difficulties in measuring chord length distributions within voxelized images. 20 Figure 8 displays a comparison of absorbed fractions for the marrow space as the source, and the bone endosteum as the target, (TBE←TM S). Although the absolute values of the absorbed fractions are low ͑Ͻ7% for both models͒, a large relative difference is observed between the two simulation approaches. One source of error in the voxel-based transport, particularly in regard to endosteal targets, is the artificially high surface area of the bone marrow interface introduced through the voxelization process ͑see Ref. 8 for more details͒. This increase in the effective endosteal surface area may be quantified through calculating surface-tovolume ratios for trabeculae within the NMR image, and comparing them to ratios taken from the Cauchy relationship:
where ͗x͘ is the mean trabeculae chord length assessed under -randomness. 
E. Estimates of marrow tissue masses in the thoracic column
To determine radionuclide S values for marrow tissues in the thoracic vertebral column, the single vertebral body tissue masses given in Table I must be scaled upward to values representative of total marrow masses in the entire thoracic column (T 1 ϪT 12 ). This scaling is performed in two steps. First, one must account for the additional marrow contained within the vertebral arch ͑processes and laminae͒. Second, the total marrow mass within a single vertebra must be scaled to a value representative of all twelve vertebrae in the thoracic column.
To accomplish the first step, high-resolution CT images ͑1.25 mm slice thickness and 0.23 mm in-plane resolution͒ of a separate single cadaveric thoracic vertebra were first reviewed to estimate the volume percentages of spongiosa found in the body and in the arch, respectively. Manual contouring of the CT images yielded volume estimates of ϳ24 cm 3 ͑75%͒ for spongiosa in the body and ϳ8 cm 3 ͑25%͒ for spongiosa within the processes and laminae. Consequently, total marrow in the vertebral body of the NMR sample may be increased by a factor of 1.33 to account for additional marrow present within the vertebral arch that was removed when the sample was harvested. These estimates are shown in column 2 of Table III. Second, absolute total marrow masses in the thoracic series taken from Table 5 .7 of the Whitwell thesis 6 can be used to scale upward values of total marrow in a single vertebrae. Due to the nature of the sample acquisition, the exact location of the vertebral body used in the present study is indeterminate, but limited to the T 2 to T 10 series. Using the data from Whitwell, 6 the total marrow in T 2 represents ϳ5.9% of the total thoracic marrow, while that in T 10 represents ϳ10.7%. Consequently, estimated ranges of total thoracic marrow in this particular 52-year-old individual can be estimated ͑column 3 of Table III͒ . Finally, it is noted that this individual had a total body mass of 54.9 kg at the time of death, and thus an additional scaling of ͑70 kg/54.9 kg͒ is applied in column 4 of Table III to estimate the range of comparable thoracic marrow in a 70 kg reference individual. These values are then compared to those from Bouchet et al. 13 for Reference Man given in the last column of Table   III .
A review of Table III indicates that closer agreement with Reference Man marrow masses is found assuming the NMR sample in the present study was taken near the top of the thoracic series. Reference Man marrow masses, nevertheless, appear slightly higher than those assuming a T 2 sample. This discrepancy may be attributed to the subject conditions of the Mechanik study 36 from which a value of 5% of total body mass was determined for the total marrow mass in Reference Man. As indicated in the review by Woodard, 37 these individuals died of wasting diseases, the consequences of which might result in ͑1͒ the loss of body mass in excess of corresponding losses in total skeletal mass, and/or ͑2͒ shifts in the bone/marrow volume fractions within trabecular regions of the skeleton due to osteopenia and/or osteoporosis. In both cases, the net effect would be an artificial increase in the estimated percentage of total body mass attributed to marrow tissues within normal individuals ͑i.e., true value Ͻ5%͒. Values in last column of Table I 
F. Example dose estimate
In this example problem, the absorbed dose to the thoracic vertebrae is estimated for an example administration of a 90 Y-labeled radiochemical used in marrow ablation. 46 Yttrium-90 is a high-energy beta-emitter with average energy of 0.934 MeV. In this example problem, let us assume an administered dose of 8900 MBq ͑240.5 mCi͒ with no biological elimination. We next assume that 50% of the injected activity localizes within the skeleton, of which 20% localizes within the spine. Furthermore, we assume that 40% of the spinal activity will localize within the thoracic vertebrae with 50% going to trabecular bone endosteum and 50% going to cortical bone endosteum. Using these estimates, 5.92 ϫ10 7 MBq s is estimated as the cumulated activity within the trabecular endosteum of the thoracic vertebral column. Dose estimates to the trabecular active marrow can then be estimated using S values for 90 Y as a source within the trabecular bone endosteum and the active marrow as the target, S(TAM ←TBE). Using the absorbed fractions from the macrostructural transport model and marrow masses taken from column 3 of Table III Due to the uncertainty of the location of the cored sample within the T 2 ϪT 10 series, it is difficult to draw specific conclusions from the dose estimates above. With the assumption that the T 2 vertebra was sampled, the dose estimate to the individual is ϳ1.4 times that given by Reference Man. When accounting for a reference total body mass of 70 kg, the dose estimates range from ϳ1.08 ͑assuming T 2 ͒ to ϳ1.96 ͑assum-ing T 10 ͒ times that given for Reference Man. Differences in the results are primarily attributed to the differences in marrow masses, suggesting that future improvements in skeletal mass determinations may be equally or even more important than improvements in absorbed fraction calculations. This study demonstrates, however, that the proposed technique of microimaging of trabecular bone specimens allows one to directly couple estimates of absorbed fractions and target tissue masses to the same anatomic sample.
IV. CONCLUSIONS
A method for utilizing NMR images as the voxelized geometry within a radiation transport code has been presented. The methodology so established, although applied to trabecular bone dosimetry in this present study, may be generally applied to microimaging of any anatomic structures for which dose estimates may be made through voxel-based transport simulations. Future extensions might even involve in vivo imaging studies tied directly to patient-specific dosimetry studies.
The results from the voxel transport suggest several conclusions. First, the volume of the region of interest used here ͑10.1 cm 3 ͒ is large enough to handle accurate transport of electrons with source energies up to 100 keV, after which a mechanism for particle reintroduction is necessary. Second, the macroscopic boundaries of the thoracic vertebral body only became significant in their influence on absorbed fraction at source energies exceeding ϳ2 MeV. Consequently, infinite medium models, such as the various existing chordlength-based models used in clinical practice, are considered accurate for relatively large skeletal sites such as the vertebrae. It is anticipated that for smaller skeletal sites such as the ribs or cranium, however, the downturn in trabecular region absorbed fractions will be observed at much lower energies resulting in increasingly inaccurate results from infinite-media models.
Third, the ϳ10% difference in absorbed fractions observed between the Bouchet et al. model and the voxel transport of the present study might not be as important as the defining sources of target tissue masses used to derive radionuclide S values. This work is believed to be unique and innovative within skeletal dosimetry in that an S value has been derived using absorbed fraction and mass data taken from the same anatomical tissue sample. In general, all previous work in skeletal dosimetry has coupled absorbed fraction data based on the trabecular microstructure of an adult male Englishman ͑measured 25 years ago͒ with the marrow mass data based on measurements of abnormal Russians ͑measured over 70 years ago͒. These Russian cadavers were individuals who were very ill and whose skeletal system may not reflect the relative portion of total body mass found in normal individuals. These disparate data sources result in a Reference Man skeletal model in which the two primary input values, absorbed fractions and tissue masses, are completely decoupled.
In this study, S values have also been calculated and compared to published values. The differences between the S values arise primarily from large differences in assumed skeletal tissue masses. This suggests that future improvements in trabecular bone dosimetry are more likely to arise from work focusing on improving estimates of the skeletal tissue masses along with patient-specific methods of determining those masses. Potential refinements to this modeling approach would include explicit consideration of the vertebral processes and laminae within the macrostructural transport model, which in the present study was limited to the vertebral body. In the S value estimates given above, it is implicitly assumed that absorbed fractions for high-energy electrons emitted from sources within the arch are identical to those from electrons emitted from within the vertebral body, an assumption which most likely overestimates dose to the tissues of the spongiosa.
NMR microscopy of trabecular bone has been shown to be a valuable tool for both the acquisition of chord length distributions for use in dosimetry models, as well as the direct coupling of those images to radiation transport codes. This work has also illustrated the importance of the chordlength acquisition technique. Given the problems associated with chord-length acquisition, 20 perhaps future work is better served using direct voxel transport. The techniques developed in this work can be applied to a variety of skeletal sites thus providing a basis for expanding the Reference Man skeletal dosimetry models to ones that are age and gender specific. Finally, it is emphasized that these techniques allow, for the first time, the direct calculation of skeletal S values which are internally consistent in regard to absorbed fractions for electrons emitted within the trabecular structure and the masses of target and source tissues needed for dose assessment. These efforts, along with continuing efforts to better quantify radionuclide and radiopharmaceutical uptake within the skeleton, will provide for improved dosimetry and prediction of subsequent biological response. 
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APPENDIX
A. Derivation of absorbed fraction convergence values for voxel transport
For the infinite trabecular region model, the absorbed fraction to a target region at high electron energies approaches a convergence value that is independent of the source region ͑trabecular marrow space TMS, trabecular bone endosteum TBE, or trabecular bone volume TBV͒. Consider an infinite region of trabecular bone that is uniformly traversed by a large number of high-energy electron tracks. The mean absorbed dose at any given point in the region is thus given as the product of the mean collisional mass stopping power and the average fluence of electrons at that point. Furthermore, the electron fluence may be expressed as the sum of all electron track lengths ͑assumed to be straight͒ that occur through the target region divided by the volume of the target region. [47] [48] [49] The mean absorbed dose to the trabecular marrow space ͑TMS͒, for example, may be written as:
where L TM S is the cumulative electron track lengths ͑as-sumed to be straight͒ through the TMS and V TM S is the total volume of the trabecular marrow space. Given a broad and uniform traversal of the entire trabecular bone region by these high-energy electrons, one may approximate L TM S as the product of the total electron pathlength through all skeletal regions within the site, L T , and the volume fraction of TMS within that site (V TM S /V T ):
͑A2͒
The total energy imparted to the TMS target is thus the product of its mean absorbed dose and the total mass of TMS:
The total energy expended in the bone endosteum and bone volume of the skeletal site would thus be given as: 
͑A5͒
The convergence value of the absorbed fraction to the TMS for a uniform high-energy electron irradiation of the trabecu-lar bone site would thus be given as the ratio of the total energy deposited to the TMS to the total energy expended within all target sites ͑TMS, TBE, and TBV͒: 
͑A8͒
At 4.0 MeV, the values of the mass collisional stopping powers for adult cortical bone ͑surrogate for TBV͒ and adult red marrow ͑surrogate for TMS and TBE͒ are 1.67 and 1.86 MeV cm 2 g Ϫ1 , respectively. 30 Using the values of target region mass given in the last column of Table I , one may estimate the convergence values of the absorbed fraction at high electron energies as 0.762, 0.0285, and 0.210 for TMS, TBE, and TBV target regions, respectively.
B. Equivalence of convergence value expressions
The two transport models have been shown to be internally consistent since absorbed fraction values at high electron energies approach those theoretically derived above ͓Eqs. ͑A6͒-͑A8͔͒ for voxel transport and those given in Ref.
14, which are reprinted here: Bouchet et If one assumes that the cumulative number of trabecular chords equals the cumulative number of marrow chords, which is reasonable given the obvious alternating occurrence of these regions, the ratio of the electron ranges in the two media must equal the ratio of their linear stopping powers within the two media. Using the data from ICRU Report 46 for 4 MeV electrons, the ratio of the linear stopping powers is found to be 1.67, which is equivalent to the ␣ϭ1.7 value Bouchet et al. used for the corresponding ratio of ranges. This agreement suggests that the two models should produce equivalent results at high source energies provided the chord distribution data is consistent with the volume ͑or mass͒ fraction displayed within the 3D voxelized model of the skeletal sample. 
